Dermatology News and Research

Latest Dermatology News and Research

PACSGEAR Image Exchange to be showcased at SIIM 2012

PACSGEAR, the leading provider of imaging connectivity for electronic health records, today announced the PACSGEAR Image Exchange, a cloud-based solution designed to securely upload and share medical images and results between facilities.

5 May 2012

Blond gene among Solomon islanders baffles researchers

It is known that skin and hair color is mostly inherited from parents but whole populations have evolved to share certain traits. It is also known that people who live closer to the equator have darker skin and hair colour to protect against the Sun. The exception is found in the Solomon Islands, an archipelago east of Papua New Guinea which has the highest proportion of natural blonds outside of Europe despite being just south of the equator.

3 May 2012

Viora offers Reaction Rent-to-Own program to medical aesthetic practitioners in Canada

Viora is excited to announce that its popular "Rent-to-Own" program for Reaction™ will now be offered in Canada to medical aesthetic practitioners. Now Canadian physicians will have the ability to introduce the leading medical aesthetic device for body contouring and skin tightening into their practice at minimal risk - with no capital investment, no financing, and no long term commitment.

2 May 2012

Non-toxic green tea shampoo to treat dandruff

Dandruff sufferers now have a non-toxic product to treat the condition, says a researcher at Georgia Health Sciences University.

2 May 2012

AlderMed enters distribution agreement with Gulmay Medical for Xstrahl-100 therapy system

AlderMed announced today it has entered into a three-year exclusive distribution agreement with Gulmay Medical, manufacturer of the Xstrahl-100 therapy system.

From Xstrahl 30 Apr 2012

Mount Sinai experts to share skin cancer prevention tips on May 7

Skin cancer is the most common form of cancer in the United States, with one in five Americans developing it over the course of their lives. It's also one of the most preventable types of cancers. Since May is Skin Cancer Awareness Month and Melanoma Monday is May 7, Mount Sinai experts are sharing tips on prevention and insight on the new FDA labeling requirements on sunscreen.

30 Apr 2012

Best and worst paid doctors: Survey

More and more U.S. doctors are regretting their career choices. According to an annual survey of physician pay called Physician Compensation Survey from Medscape/WebMD this is in spite of the hefty amounts that they make each year. However the survey reveals that some specialities may earn more than others.

29 Apr 2012

Study describes structure and function of the stratum corneum

A research team at Karolinska Institutet in Sweden has succeeded in describing the structure and function of the outermost layer of the skin - the stratum corneum - at a molecular level. This opens the way not only for the large-scale delivery of drugs via the skin, but also for a deeper understanding of skin diseases.

27 Apr 2012

New URMC trial to evaluate carvedilol for high blood pressure

Researchers at the University of Rochester Medical Center are testing whether different doses of an established blood pressure medication can provide the same benefits as a standard dose in people with mild hypertension, possibly with fewer side effects and at a lower cost. The newly launched clinical trial, funded with a $1.9 million grant from the National Heart Lung and Blood Institute, is the first of its kind in the United States.

27 Apr 2012

A melanoma cloaking protein

Johns Hopkins and Yale scientists have found that melanoma cells use a cloaking protein to hide from immune cells poised to attack the cancer. Nearly 40 percent of their sampling of melanoma tissues contained the B7-H1 protein, also called PD-L1, and scientists say it could be used as a target for new therapies.

26 Apr 2012

Melanomas express B7-H1 protein to hide from T-cells

26 Apr 2012

Clinical and Translational Science Institute-Children's National awards pilot grant to GW researchers

GW researchers in the School of Medicine, Jeffrey M. Bethony, Ph.D., Associate Professor of Microbiology, Immunology, and Tropical Medicine and David Diemert, M.D., FRCP(C), Associate Research Professor of Microbiology, Immunology, and Tropical Medicine and Director of Clinical Trials for the Sabin Vaccine Institute's Product Development Partnership (PDP), have been awarded a Pilot Grant from the Clinical and Translational Science Institute-Children's National.

25 Apr 2012

R-Tech Ueno completes RK-023 phase I study on hypotrichosis of the eyelashes

R-Tech Ueno is pleased to announce the completion of a phase I clinical study of RK-023, a new compound that is being developed for the treatment of hypotrichosis of the eyelashes.

24 Apr 2012

Loyola dermatologists to offer free melanoma screenings in May

Dermatologists from Loyola University Health System will offer free skin cancer screenings in May as part of Skin Cancer Detection and Prevention Month.

24 Apr 2012

Vietnam asks for international help to tackle mystery skin disease

Vietnam has asked for international aid to get to the bottom of a mystery skin infection that has already killed 19 people. More than 170 people in the country's central province of Quang Ngai have reported symptoms reports say.

23 Apr 2012

India's most-renowned homeopath receives Padma Shri award

Dr. Mukesh Batra, India's most-renowned homeopath, was conferred with the Padma Shri today, the country's fourth highest civilian award, by the President, Smt. Pratibha Patel for his exceptional and distinguished service in the field of medicine.

23 Apr 2012

More than 19,300 people participated at AAD’s 70th Annual Meeting

The American Academy of Dermatology's 70th Annual Meeting, recently held in San Diego from March 16-20, had a record attendance of more than 19,300 people from more than 102 countries.

17 Apr 2012

Vanda acquires license from Lilly to develop and commercialize NK-1R antagonist

Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, announced today that it has acquired an exclusive world-wide license from Eli Lilly and Company (Lilly) to develop and commercialize a small molecule neurokinin 1 receptor (NK-1R) antagonist for all human indications.

17 Apr 2012

Toxic nail varnish at salons raises concerns

It has been long seen that workers at nail salons suffer health problems. Workers have more headaches, respiratory problems and skin irritations than the general population and are exposed to chemicals at higher than recommended levels, according to research in scientific journals.

12 Apr 2012

Valeant acquires Pedinol Pharmacal

Valeant Pharmaceuticals International, Inc. announced today that Valeant has acquired Pedinol Pharmacal, Inc., a podiatry-focused, privately-owned specialty pharmaceutical company based in the U.S., for less than 1.5 times sales.

12 Apr 2012